52
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Intracerebral hemorrhage (ICH) accounted for 9% to 27% of all strokes worldwide in the last decade, with high early case fatality and poor functional outcome. In view of recent randomized controlled trials (RCTs) of the management of ICH, the European Stroke Organisation (ESO) has updated its evidence-based guidelines for the management of ICH. A multidisciplinary writing committee of 24 researchers from 11 European countries identified 20 questions relating to ICH management and created recommendations based on the evidence in RCTs using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. We found moderate- to high-quality evidence to support strong recommendations for managing patients with acute ICH on an acute stroke unit, avoiding hemostatic therapy for acute ICH not associated with antithrombotic drug use, avoiding graduated compression stockings, using intermittent pneumatic compression in immobile patients, and using blood pressure lowering for secondary prevention. We found moderate-quality evidence to support weak recommendations for intensive lowering of systolic blood pressure to <140 mmHg within six-hours of ICH onset, early surgery for patients with a Glasgow Coma Scale score 9-12, and avoidance of corticosteroids. These guidelines inform the management of ICH based on evidence for the effects of treatments in RCTs. Outcome after ICH remains poor, prioritizing further RCTs of interventions to improve outcome. © 2014 World Stroke Organization.

          Related collections

          Most cited references111

          • Record: found
          • Abstract: found
          • Article: not found

          Medication adherence: its importance in cardiovascular outcomes.

          Medication adherence usually refers to whether patients take their medications as prescribed (eg, twice daily), as well as whether they continue to take a prescribed medication. Medication nonadherence is a growing concern to clinicians, healthcare systems, and other stakeholders (eg, payers) because of mounting evidence that it is prevalent and associated with adverse outcomes and higher costs of care. To date, measurement of patient medication adherence and use of interventions to improve adherence are rare in routine clinical practice. The goals of the present report are to address (1) different methods of measuring adherence, (2) the prevalence of medication nonadherence, (3) the association between nonadherence and outcomes, (4) the reasons for nonadherence, and finally, (5) interventions to improve medication adherence.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial

            Summary Background The balance of risk and benefit from early neurosurgical intervention for conscious patients with superficial lobar intracerebral haemorrhage of 10–100 mL and no intraventricular haemorrhage admitted within 48 h of ictus is unclear. We therefore tested the hypothesis that early surgery compared with initial conservative treatment could improve outcome in these patients. Methods In this international, parallel-group trial undertaken in 78 centres in 27 countries, we compared early surgical haematoma evacuation within 12 h of randomisation plus medical treatment with initial medical treatment alone (later evacuation was allowed if judged necessary). An automatic telephone and internet-based randomisation service was used to assign patients to surgery and initial conservative treatment in a 1:1 ratio. The trial was not masked. The primary outcome was a prognosis-based dichotomised (favourable or unfavourable) outcome of the 8 point Extended Glasgow Outcome Scale (GOSE) obtained by questionnaires posted to patients at 6 months. Analysis was by intention to treat. This trial is registered, number ISRCTN22153967. Findings 307 of 601 patients were randomly assigned to early surgery and 294 to initial conservative treatment; 298 and 291 were followed up at 6 months, respectively; and 297 and 286 were included in the analysis, respectively. 174 (59%) of 297 patients in the early surgery group had an unfavourable outcome versus 178 (62%) of 286 patients in the initial conservative treatment group (absolute difference 3·7% [95% CI −4·3 to 11·6], odds ratio 0·86 [0·62 to 1·20]; p=0·367). Interpretation The STICH II results confirm that early surgery does not increase the rate of death or disability at 6 months and might have a small but clinically relevant survival advantage for patients with spontaneous superficial intracerebral haemorrhage without intraventricular haemorrhage. Funding UK Medical Research Council.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

              The aim of this guideline is to present current and comprehensive recommendations for the diagnosis and treatment of acute spontaneous intracerebral hemorrhage. A formal literature search of MEDLINE was performed. Data were synthesized with the use of evidence tables. Writing committee members met by teleconference to discuss data-derived recommendations. The American Heart Association Stroke Council's Levels of Evidence grading algorithm was used to grade each recommendation. Prerelease review of the draft guideline was performed by 6 expert peer reviewers and by the members of the Stroke Council Scientific Statements Oversight Committee and Stroke Council Leadership Committee. It is intended that this guideline be fully updated in 3 years' time. Evidence-based guidelines are presented for the care of patients presenting with intracerebral hemorrhage. The focus was subdivided into diagnosis, hemostasis, blood pressure management, inpatient and nursing management, preventing medical comorbidities, surgical treatment, outcome prediction, rehabilitation, prevention of recurrence, and future considerations. Intracerebral hemorrhage is a serious medical condition for which outcome can be impacted by early, aggressive care. The guidelines offer a framework for goal-directed treatment of the patient with intracerebral hemorrhage.
                Bookmark

                Author and article information

                Journal
                International Journal of Stroke
                International Journal of Stroke
                Wiley
                1747-4930
                1747-4949
                September 18 2014
                October 2014
                August 24 2014
                October 2014
                : 9
                : 7
                : 840-855
                Affiliations
                [1 ]Department of Neurology, Klinikum Frankfurt Höchst, Frankfurt, Germany
                [2 ]Department of Neurology, Heidelberg University, Heidelberg, Germany
                [3 ]Division of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
                [4 ]Department of Neurology, Neurointensive Care Unit, Medical University Hospital, Innsbruck, Austria
                [5 ]Department of Neurology, Bispebjerg Hospital, University of Copenhagen, Denmark
                [6 ]Department of Neurology, EA 1046, Université Lille Nord de France, Lille, France
                [7 ]Department of Neurology, Clinical Center, Debrecen University, Hungary
                [8 ]Department of Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
                [9 ]Department of Neurosurgery, Sheba Medical Center, Tel Aviv, Israel
                [10 ]Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands
                [11 ]Institute of Neurosciences, Newcastle University, Newcastle, UK
                [12 ]Department of Neurology, Hospital Universitari Vall d'Hebrón, Barcelona, Spain
                [13 ]Department of Neurology, Skåne University Hospital, Malmö, Sweden
                [14 ]Division of Clinical Neurosciences, Turku University Hospital and University of Turku, Turku, Finland
                [15 ]Department of Neurosurgery, Saarland University Hospital, Homburg-Saar, Germany
                [16 ]Department of Neurology, Hôpital Lariboisière, Université Paris VII – Denis Diderot, Paris, France
                [17 ]Department of Neurology, Helsinki University Central Hospital, Helsinki, Finland
                [18 ]Cochrane Stroke Group, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
                [19 ]Depatment of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy
                [20 ]Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany
                [21 ]Stiftung Deutsche Schlaganfall-Hilfe, Gütersloh, Germany
                Article
                10.1111/ijs.12309
                25156220
                0a33f15e-9463-4e30-ad37-d56250ebed05
                © 2014

                http://journals.sagepub.com/page/policies/text-and-data-mining-license

                History

                Comments

                Comment on this article